Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar belakang: Rehospitalisasi 30 hari pada gagal jantung menyebabkan perburukan prognosis dan paling sering terjadi karena kongesti hemodinamik yang ditandai oleh tekanan pengisian ventrikel kiri (left ventricular end diastolic pressure/LVEDP) persisten tinggi. Oleh karena itu, dekongesti komplit harus dipastikan sebelum pasien pulang dari perawatan. Salah satu modalitas yang potensial adalah skor SAFE melalui evaluasi 3 komponen kongesti hemodinamik, yaitu: pompa (ejection fraction/EF), pipa (internal jugular vein collapsibility index/IJVCI dan inferior vena cava/IVC) dan jaringan interstisial (B-lines). Pada studi ini, rerata E/e’ ditambahkan pada skor SAFE dengan pertimbangan nilai prognostik rerata E/e’ dalam memprediksi kejadian rehospitalisasi.Tujuan: Membandingkan skor SAFE dan skor SAFE+rerata E/e’ dalam memprediksi rehospitalisasi 30 hari terkait gagal jantung akut.Metode: Dilakukan studi kohort prospektif dengan melibatkan 82 orang pasien gagal jantung akut yang dirawat di RSJPDHK. Analisis bivariat dan multivariat dilakukan untuk membandingkan kemampuan prediksi skor SAFE dan skor SAFE+rerata E/e’ terhadap rehospitalisasi 30 hari terkait gagal jantung akut.Hasil: Insidensi rehospitalisasi 30 hari terkait gagal jantung akut mencapai 19,5%. Kurva Kaplan-Meier menunjukkan rehospitalisasi lebih rendah pada kondisi euvolemia daripada hipervolemia (p 0,003). Skor SAFE+rerata E/e’ memiliki kemampuan prediksi rehospitalisasi 30 hari yang lebih baik daripada skor SAFE (AUC 0,77 [95% CI: 0,64 – 0,89] vs AUC 0,74 [95% CI: 0,62 – 0,85]).Kesimpulan: Skor SAFE+rerata E/e’ memiliki kemampuan prediksi rehospitalisasi 30 hari terkait gagal jantung akut yang lebih baik daripada skor SAFE.

---

Background: Short-term-rehospitalization worsens prognosis and frequently occurs due to persistently high LVEDP (hemodynamic congestion) among patients with heart failure (HF). Therefore, it is necessary to ascertain complete decongestion prior to hospital discharge. SAFE score is a potential scoring system to do so because it measures 3 main components of hemodynamic congestion: pump (EF), pipe (IJVCI and IVC) and interstitial tissue (B-lines). In this study, average E/e’ is added to SAFE score considering its clinically significant prognostic value in predicting risk of rehospitalization among patients with HF.

Aim: To compare SAFE score and SAFE score+average E/e’ in predicting 30-day-acute HF (AHF)- related-rehospitalization.

Methods: A prospective cohort study was conducted by involving 82 patients admitted with AHF in National Cardiovascular Center Harapan Kita (NCCHK). Bivariate and multivariate analysis were done to find out which of the 2 models: SAFE score and SAFE score+average E/e’ could better predict risk of 30-day-AHF-related-rehospitalization.

Results: The incidence of 30-day-AHF-related-rehospitalization in this study was 19,5%. By using Kaplan-Meier curve, we identified significantly lower 30-day-AHF-related-rehospitalization in patients discharged with euvolemia than those with hypervolemia (p 0,003). SAFE score+average E/e’ had better predictive properties than SAFE score regarding 30-day-AHF-related-rehospitalization (AUC 0,77 [95% CI: 0,64 – 0,89] vs AUC 0,74 [95% CI: 0,62 – 0,85]).

Conclusion: SAFE score+average E/e’ had better predictive properties than SAFE score regarding 30- day-AHF-related-rehospitalization."

"Latar belakang: Rehospitalisasi 30 hari pada gagal jantung menyebabkan perburukan prognosis dan paling sering terjadi karena kongesti hemodinamik yang ditandai oleh tekanan pengisian ventrikel kiri (left ventricular end diastolic pressure/LVEDP) persisten tinggi. Oleh karena itu, dekongesti komplit harus dipastikan sebelum pasien pulang dari perawatan. Salah satu modalitas yang potensial adalah skor SAFE melalui evaluasi 3 komponen kongesti hemodinamik, yaitu: pompa (ejection fraction/EF), pipa (internal jugular vein collapsibility index/IJVCI dan inferior vena cava/IVC) dan jaringan interstisial (B-lines). Pada studi ini, rerata E/e’ ditambahkan pada skor SAFE dengan pertimbangan nilai prognostik rerata E/e’ dalam memprediksi kejadian rehospitalisasi.Tujuan: Membandingkan skor SAFE dan skor SAFE+rerata E/e’ dalam memprediksi rehospitalisasi 30 hari terkait gagal jantung akut.Metode: Dilakukan studi kohort prospektif dengan melibatkan 82 orang pasien gagal jantung akut yang dirawat di RSJPDHK. Analisis bivariat dan multivariat dilakukan untuk membandingkan kemampuan prediksi skor SAFE dan skor SAFE+rerata E/e’ terhadap rehospitalisasi 30 hari terkait gagal jantung akut.Hasil: Insidensi rehospitalisasi 30 hari terkait gagal jantung akut mencapai 19,5%. Kurva Kaplan-Meier menunjukkan rehospitalisasi lebih rendah pada kondisi euvolemia daripada hipervolemia (p 0,003). Skor SAFE+rerata E/e’ memiliki kemampuan prediksi rehospitalisasi 30 hari yang lebih baik daripada skor SAFE (AUC 0,77 [95% CI: 0,64 – 0,89] vs AUC 0,74 [95% CI: 0,62 – 0,85]).Kesimpulan: Skor SAFE+rerata E/e’ memiliki kemampuan prediksi rehospitalisasi 30 hari terkait gagal jantung akut yang lebih baik daripada skor SAFE.

---

Background: Short-term-rehospitalization worsens prognosis and frequently occurs due to persistently high LVEDP (hemodynamic congestion) among patients with heart failure (HF). Therefore, it is necessary to ascertain complete decongestion prior to hospital discharge. SAFE score is a potential scoring system to do so because it measures 3 main components of hemodynamic congestion: pump (EF), pipe (IJVCI and IVC) and interstitial tissue (B-lines). In this study, average E/e’ is added to SAFE score considering its clinically significant prognostic value in predicting risk of rehospitalization among patients with HF.

Aim: To compare SAFE score and SAFE score+average E/e’ in predicting 30-day-acute HF (AHF)- related-rehospitalization.

Methods: A prospective cohort study was conducted by involving 82 patients admitted with AHF in National Cardiovascular Center Harapan Kita (NCCHK). Bivariate and multivariate analysis were done to find out which of the 2 models: SAFE score and SAFE score+average E/e’ could better predict risk of 30-day-AHF-related-rehospitalization.

Results: The incidence of 30-day-AHF-related-rehospitalization in this study was 19,5%. By using Kaplan-Meier curve, we identified significantly lower 30-day-AHF-related-rehospitalization in patients discharged with euvolemia than those with hypervolemia (p 0,003). SAFE score+average E/e’ had better predictive properties than SAFE score regarding 30-day-AHF-related-rehospitalization (AUC 0,77 [95% CI: 0,64 – 0,89] vs AUC 0,74 [95% CI: 0,62 – 0,85]).

Conclusion: SAFE score+average E/e’ had better predictive properties than SAFE score regarding 30- day-AHF-related-rehospitalization."

"Regurgitasi Aorta (RA) merupakan penyakit jantung katup terbanyak ketiga setelah stenosis aorta dan regurgitasi mitral dengan prevalensi sebesar 0.5% dari total populasi global. Berbagai faktor prediktor mortalitas dan kesintasan pada pasien RA telah banyak dipelajari diberbagai negara. Akan tetapi, studi yang mempelajari mengenai faktor prognostik terhadap kesintasan paska PKA pada pasien RA berat belum pernah dilakukan di Indonesia. Studi ini merupakan penelitian prognostik eksploratif dengan pendekatan kohort retroprospektif melibatkan 964 pasien dengan RA Berat yang berobat di RS Pusat Jantung Nasional Harapan Kita sejak Januari 2016 sampai Desember 2022. Dilakukan pengambilan data klinis, data ekokardiografi transtorakal, data prosedur pembedahan. Luaran primer adalah angka kesintasan dan angka mortalitas. Sebanyak total 383 pasien berhasil dilakukan analisis akhir. Sebagian besar subjek laki-laki (73,1%) dengan median usia 44 tahun (15-81). Prediktor bermakna terhadap angka kesintasan dan mortalitas pasien RA berat adalah penyakit ginjal kronis (OR 1,81, 95% CI 1,11-2,96; p<0,017), DASVKi ≥48,2 mm (OR 1,54, 95% CI 0,94-2,52;p<0,087), IMVK ≥173,5 g/m2 (OR 2,22, 95% CI 1,14-4,33;p<0,019), IVAK >34 mm/m2 (OR 2,38, 95% CI 1,18-4,79;p<0,015), Tanpa PKA (OR 4,33, 95% CI 2,68-7,00;p<0,001). Variabel Tanpa PKA merupakan prediktor angka kematian bermakna paling tinggi dengan peningkatan risiko kematian sebesar 4,33 kali (95% IK 2,688-7,00), p<0,001. Penyakit Ginjal Kronis, DASVKi ≥48,2 mm, IMVK ≥173,5 g/m2 IVAK >34 mm/m2 dan Tanpa PKA merupakan prediktor mortalitas bermakna pada pasien RA berat. Penyakit Ginjal Kronis merupakan prediktor kematian bermakna dari faktor klinis, ukuran DASVKi, IVMK, dan IVAK merupakan prediktor kematian bermakna dari faktor ekokardiografi serta Tanpa PKA merupakan prediktor kematian bermakna dari faktor prosedur bedah. Tanpa PKA merupakan prediktor angka kematian bermakna paling tinggi dengan peningkatan risiko kematian sebesar 4,33 kali.

---

Aortic Regurgitation (AR) is the third most common valvular heart disease after aortic stenosis and mitral regurgitation, with a prevalence of 0.5% of the global population. Various predictors of mortality and survival in AR patients have been extensively studied in different countries. However, studies focusing on prognostic factors for survival post-AVR in severe AR patients have not been conducted in Indonesia. To investigate clinical, echocardiographic, and AVR procedure predictors of survival in patients with severe AR. Methods: This is an exploratory prognostic study with a retrospective cohort approach involving 964 patients with severe Aortic Regurgitation treated at the National Heart Center Harapan Kita from January 2016 to December 2022. Data collection included clinical data, transthoracic echocardiographic data, and surgical procedure data. Primary outcomes analyzed were survival and mortality rates assessed over >1 year. A total of 383 patients were included in the final analysis. The majority of subjects were male (73.1%) with a median age of 44 years (15-81). Significant predictors of survival and mortality rates in severe RA patients are chronic kidney disease (OR 1.81, 95% CI 1.11-2.96; p < 0.017), LVESD ≥ 48.2 mm (OR 1.54, 95% CI 0.94-2.52; p < 0.087), LVMI ≥ 173.5 g/m2 (OR 2.22, 95% CI 1.14-4.33; p < 0.019), LAVI > 34 mm/m2 (OR 2.38, 95% CI 1.18-4.79; p < 0.015), and No AVR (OR 4.33, 95% CI 2.68-7.00; p < 0.001). The No AVR variable exhibits the highest significant mortality prediction with OR 4,33, 95% CI 2.688-7.00 and p < 0.001. Chronic kidney disease, LVESD ≥ 48.2 mm, LVMI ≥ 173.5 g/m2, LAVI > 34 mm/m2, and No AVR are significant mortality predictors in severe RA patients. Chronic kidney disease is a predictor of significant mortality among clinical factors, while LVEDS, LVMI, and LAVI are predictors among echocardiographic factors, and No AVR is a predictor of procedural factors. No AVR represents the highest significant mortality predictor with a 4.33-fold increased risk of death."